Sign in to view content

Subretinal Delivery of RGX-314: Gene Therapy for Neovascular Age-Related Macular Degeneration

Ashkan M. Abbey, MD, FASRS, FAAO

Video
Published 2023

Related

AAV-RPGR Gene Therapy for RPGR-Associated X-Linked Retinitis Pigmentosa: 6-month Results From a Phase 1/2 Clinical Trial
Michel Michaelides, BSc, MB BS, MD(Res), FRCOphth, FACS
Updates from the Field
2020
Suprachoroidally delivered gene therapy via non-viral DNA nanoparticles
Christine Kay, MD
On Demand Cases, Courses, and Papers
2019
RGX-314 for Neovascular AMD: Ongoing Phase I/IIa Results for Cohorts 1-5
Arshad M. Khanani, MD, MA, FASRS
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more